Report Detail

Request for Sample of this report

Other Global Novel Antiviral Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4596463
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Novel Antiviral Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs are actively seeking host factors, both in the initial stage of viral infection and in the later stages of nuclear transport of viral RNP complexes, to produce new drugs with new modes of action without drug resistance.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Novel Antiviral Drugs industry chain, the market status of Hepatitis Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), HIV/AIDS Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Novel Antiviral Drugs.
Regionally, the report analyzes the Novel Antiviral Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Novel Antiviral Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Novel Antiviral Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Novel Antiviral Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Reverse Transcriptase Inhibitors, Protease Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Novel Antiviral Drugs market.
Regional Analysis: The report involves examining the Novel Antiviral Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Novel Antiviral Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Novel Antiviral Drugs:
Company Analysis: Report covers individual Novel Antiviral Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Novel Antiviral Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis Therapeutics, HIV/AIDS Therapeutics).
Technology Analysis: Report covers specific technologies relevant to Novel Antiviral Drugs. It assesses the current state, advancements, and potential future developments in Novel Antiviral Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Novel Antiviral Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Novel Antiviral Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Other
Market segment by Application
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Other
Market segment by players, this report covers
Roche Holding AG
GlaxoSmithKline
Bristol-Myers Squibb
AbbVie
Johnson & Johnson
Merck & Co
Novartis
Dr Reddy’s
Gilead Sciences
Aurobindo Pharma
Cipla
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Novel Antiviral Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Novel Antiviral Drugs, with revenue, gross margin and global market share of Novel Antiviral Drugs from 2019 to 2024.
Chapter 3, the Novel Antiviral Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Novel Antiviral Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Novel Antiviral Drugs.
Chapter 13, to describe Novel Antiviral Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Novel Antiviral Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Novel Antiviral Drugs by Type
    • 1.3.1 Overview: Global Novel Antiviral Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Novel Antiviral Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Reverse Transcriptase Inhibitors
    • 1.3.4 Protease Inhibitors
    • 1.3.5 Fusion Inhibitors
    • 1.3.6 Immune System Modulators
    • 1.3.7 Other
  • 1.4 Global Novel Antiviral Drugs Market by Application
    • 1.4.1 Overview: Global Novel Antiviral Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hepatitis Therapeutics
    • 1.4.3 HIV/AIDS Therapeutics
    • 1.4.4 Herpes Therapeutics
    • 1.4.5 Influenza Therapeutics
    • 1.4.6 Other
  • 1.5 Global Novel Antiviral Drugs Market Size & Forecast
  • 1.6 Global Novel Antiviral Drugs Market Size and Forecast by Region
    • 1.6.1 Global Novel Antiviral Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Novel Antiviral Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Novel Antiviral Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Novel Antiviral Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Novel Antiviral Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Novel Antiviral Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Novel Antiviral Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche Holding AG
    • 2.1.1 Roche Holding AG Details
    • 2.1.2 Roche Holding AG Major Business
    • 2.1.3 Roche Holding AG Novel Antiviral Drugs Product and Solutions
    • 2.1.4 Roche Holding AG Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Holding AG Recent Developments and Future Plans
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Novel Antiviral Drugs Product and Solutions
    • 2.2.4 GlaxoSmithKline Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.3 Bristol-Myers Squibb
    • 2.3.1 Bristol-Myers Squibb Details
    • 2.3.2 Bristol-Myers Squibb Major Business
    • 2.3.3 Bristol-Myers Squibb Novel Antiviral Drugs Product and Solutions
    • 2.3.4 Bristol-Myers Squibb Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.4 AbbVie
    • 2.4.1 AbbVie Details
    • 2.4.2 AbbVie Major Business
    • 2.4.3 AbbVie Novel Antiviral Drugs Product and Solutions
    • 2.4.4 AbbVie Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 AbbVie Recent Developments and Future Plans
  • 2.5 Johnson & Johnson
    • 2.5.1 Johnson & Johnson Details
    • 2.5.2 Johnson & Johnson Major Business
    • 2.5.3 Johnson & Johnson Novel Antiviral Drugs Product and Solutions
    • 2.5.4 Johnson & Johnson Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.6 Merck & Co
    • 2.6.1 Merck & Co Details
    • 2.6.2 Merck & Co Major Business
    • 2.6.3 Merck & Co Novel Antiviral Drugs Product and Solutions
    • 2.6.4 Merck & Co Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck & Co Recent Developments and Future Plans
  • 2.7 Novartis
    • 2.7.1 Novartis Details
    • 2.7.2 Novartis Major Business
    • 2.7.3 Novartis Novel Antiviral Drugs Product and Solutions
    • 2.7.4 Novartis Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Novartis Recent Developments and Future Plans
  • 2.8 Dr Reddy’s
    • 2.8.1 Dr Reddy’s Details
    • 2.8.2 Dr Reddy’s Major Business
    • 2.8.3 Dr Reddy’s Novel Antiviral Drugs Product and Solutions
    • 2.8.4 Dr Reddy’s Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Dr Reddy’s Recent Developments and Future Plans
  • 2.9 Gilead Sciences
    • 2.9.1 Gilead Sciences Details
    • 2.9.2 Gilead Sciences Major Business
    • 2.9.3 Gilead Sciences Novel Antiviral Drugs Product and Solutions
    • 2.9.4 Gilead Sciences Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Gilead Sciences Recent Developments and Future Plans
  • 2.10 Aurobindo Pharma
    • 2.10.1 Aurobindo Pharma Details
    • 2.10.2 Aurobindo Pharma Major Business
    • 2.10.3 Aurobindo Pharma Novel Antiviral Drugs Product and Solutions
    • 2.10.4 Aurobindo Pharma Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Aurobindo Pharma Recent Developments and Future Plans
  • 2.11 Cipla
    • 2.11.1 Cipla Details
    • 2.11.2 Cipla Major Business
    • 2.11.3 Cipla Novel Antiviral Drugs Product and Solutions
    • 2.11.4 Cipla Novel Antiviral Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Cipla Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Novel Antiviral Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Novel Antiviral Drugs by Company Revenue
    • 3.2.2 Top 3 Novel Antiviral Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Novel Antiviral Drugs Players Market Share in 2023
  • 3.3 Novel Antiviral Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Novel Antiviral Drugs Market: Region Footprint
    • 3.3.2 Novel Antiviral Drugs Market: Company Product Type Footprint
    • 3.3.3 Novel Antiviral Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Novel Antiviral Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Novel Antiviral Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Novel Antiviral Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Novel Antiviral Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Novel Antiviral Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Novel Antiviral Drugs Consumption Value by Application (2019-2030)
  • 6.3 North America Novel Antiviral Drugs Market Size by Country
    • 6.3.1 North America Novel Antiviral Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Novel Antiviral Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Novel Antiviral Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Novel Antiviral Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Novel Antiviral Drugs Market Size by Country
    • 7.3.1 Europe Novel Antiviral Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Novel Antiviral Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Novel Antiviral Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Novel Antiviral Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Novel Antiviral Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Novel Antiviral Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Novel Antiviral Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Novel Antiviral Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Novel Antiviral Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Novel Antiviral Drugs Market Size by Country
    • 9.3.1 South America Novel Antiviral Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Novel Antiviral Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Novel Antiviral Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Novel Antiviral Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Novel Antiviral Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Novel Antiviral Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Novel Antiviral Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Novel Antiviral Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Novel Antiviral Drugs Market Drivers
  • 11.2 Novel Antiviral Drugs Market Restraints
  • 11.3 Novel Antiviral Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Novel Antiviral Drugs Industry Chain
  • 12.2 Novel Antiviral Drugs Upstream Analysis
  • 12.3 Novel Antiviral Drugs Midstream Analysis
  • 12.4 Novel Antiviral Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Novel Antiviral Drugs. Industry analysis & Market Report on Novel Antiviral Drugs is a syndicated market report, published as Global Novel Antiviral Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Novel Antiviral Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,201.60
    		4,802.40
    		6,403.20
    		530,108.40
    		795,162.60
    		1,060,216.80
    		292,772.40
    		439,158.60
    		585,544.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo